We are in pursuit of identifying and developing life-saving solutions for global healthcare problems with a focus on cancer diagnostics and cure.
Trusted by:
Why choose us?
Our approach is grounded in rigorous research, advanced platforms, and a commitment to meaningful outcomes.
11000+
Patients Served Globally
450+
Doctors Trust Us
100+
Publications
13+
Years of Excellence
Patented Techologies
Proprietary innovations designed to deliver precision, reliability, and real-world impact.
Regulatory Approved
Regulatory-approved solutions built to meet the highest standards of safety, compliance, and clinical integrity.
Our Publications
In collaboration with researchers and thought leaders around the world, Actorius Innovations' Team combines scientific expertise with cutting-edge innovation to advance the frontiers of cancer care. The research behind our products are supported by 100+ scientific publications presented at leading global forums such as ASCO, AACR, ESMO, ISLB, etc
Sep 1, 2026
Longitudinal Assessment of Circulating Tumor Cells Expressing PD-L1 and Clusters in Esophageal Cancer Patients
A longitudinal study of 110 esophageal cancer patients evaluated CTCs, PD-L1 expression, and CTC clusters, highlighting their potential as predictive biomarkers for treatment outcomes and occult minimal cellular residual disease.
Aug 30, 2026
Detection of Androgen Receptor Splice Variant 7 in Circulating Tumor Cells for Dynamic Treatment Decision in Prostate Cancer Patients
This study evaluated AR-V7 in CTCs and clusters from prostate cancer patients, highlighting its potential to predict ARSI resistance and support dynamic treatment decisions.
Mar 14, 2026
Dr. Jayant Khandare Leads Actorius with Pathbreaking Innovations in Cancer Detection and Metastasis Control
Actorius Innovations and Research Pvt Ltd, a pioneering Indo-US biotechnology company revolutionizing oncology through advanced circulating tumor cell (CTC) technologies, continues to make significant strides under the visionary leadership of Dr. Jayant Khandare, Founder, Managing Director, and Chief Scientific Officer.
Actorius focuses on understanding cancer at the cellular level and translating that insight into precise, actionable outcomes. Our platforms are designed to look deeper, act earlier, and support more confident decisions.
Our solutions are built for clinicians, researchers, healthcare partners, and institutions seeking advanced tools for cancer detection, analysis, and monitoring.
We combine advanced biomaterials, biological insight, and data-driven analysis to study cancer behavior in detail—enabling earlier detection and more targeted intervention.
Our work spans both research and translational applications. Some solutions are designed for research use, while others are developed with clinical deployment in mind, subject to regulatory requirements.
You can explore our latest blogs, newsletters, press releases, case studies, and events in the Resources section to stay informed about our progress and insights.